Philip M Robson, PhD Email Philip Robson
- INSTRUCTOR | Diagnostic, Molecular and Interventional Radiology
Dr. Robson is an Instructor of Radiology in the Translational and Molecular imaging Institute and is a member of the Cardiovascular Imaging group. Dr. Robson’s research includes the development of hybrid positron emission tomography (PET) magnetic resonance (MR) imaging technology and its applications in cardiovascular disease, including coronary and carotid artery disease, cardiac sarcoidosis and other cardiomyopathies. His work has led to some of the first successful applications of imaging the activity of micro-calcification and inflammation in atherosclerotic plaque in the coronary arteries using 18F-fluoride and 18F-FDG PET/MR imaging and the development of combined PET and MR protocols for evaluating cardiac sarcoidosis and amyloidosis. He is currently working on methods for MR-based motion correction of PET data, MR-based attenuation correction and complementary anatomical and functional cardiac MR imaging for optimizing cardiac and coronary PET/MR imaging. Dr. Robson’s research includes partnerships with clinical investigators in the Cardiovascular Institute as well as national and international collaborators. Before joining Mount Sinai, Dr. Robson worked as a postdoctoral fellow at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA. He was awarded doctoral and undergraduate degrees in Physics by the University of Cambridge, UK.
Atherosclerosis, Cardiovascular, Imaging, MRI, Magnetic Resonance Imaging, Positron Emission Tomography
MSci / BA, University of Cambridge
PhD, University of Cambridge
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Robson did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.